3.35
Precedente Chiudi:
$3.37
Aprire:
$3.38
Volume 24 ore:
1.06M
Relative Volume:
0.93
Capitalizzazione di mercato:
$1.23B
Reddito:
$159.54M
Utile/perdita netta:
$5.06M
Rapporto P/E:
-761.36
EPS:
-0.0044
Flusso di cassa netto:
$26.19M
1 W Prestazione:
+6.69%
1M Prestazione:
+4.36%
6M Prestazione:
+31.89%
1 anno Prestazione:
+25.47%
Cronos Group Inc Stock (CRON) Company Profile
Nome
Cronos Group Inc
Settore
Telefono
(416) 504-0004
Indirizzo
4491 CONCESSION RD 12, STAYNER, ON
Compare CRON vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
CRON
Cronos Group Inc
|
3.35 | 1.16B | 159.54M | 5.06M | 26.19M | -0.0044 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.91 | 58.31B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
38.98 | 43.22B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
HLN
Haleon Plc Adr
|
9.28 | 40.41B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
ZTS
Zoetis Inc
|
71.40 | 30.15B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
494.63 | 21.32B | 3.17B | 1.29B | 1.01B | 27.09 |
Cronos Group Inc Stock (CRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | Canaccord Genuity | Buy |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-28 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2022-05-11 | Aggiornamento | CIBC | Neutral → Sector Outperform |
| 2022-03-22 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-27 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-11-18 | Ripresa | BofA Securities | Underperform |
| 2021-04-28 | Ripresa | BofA Securities | Underperform |
| 2021-02-22 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2020-06-24 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-27 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-04-02 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-03-31 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2020-03-04 | Aggiornamento | MKM Partners | Neutral → Buy |
| 2020-03-03 | Downgrade | Stifel | Buy → Hold |
| 2019-10-18 | Aggiornamento | Stifel | Hold → Buy |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-09-05 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-08-13 | Iniziato | Piper Jaffray | Overweight |
| 2019-08-09 | Aggiornamento | Canaccord Genuity | Sell → Hold |
| 2019-06-28 | Iniziato | Consumer Edge Research | Equal Weight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2019-04-17 | Iniziato | BofA/Merrill | Underperform |
| 2019-03-27 | Downgrade | Canaccord Genuity | Hold → Sell |
| 2019-02-25 | Iniziato | Jefferies | Underperform |
| 2019-01-18 | Iniziato | CIBC | Sector Outperform |
Mostra tutto
Cronos Group Inc Borsa (CRON) Ultime notizie
Cronos Group Inc. (NASDAQ:CRON) Given Average Rating of "Hold" by Brokerages - MarketBeat
Cronos Group Extends Long Stop Date To October 15 For Canadelaar BV DealSEC Filing - TradingView
Cronos Group Inc. (TSX:CRON) Advances as Cannabis Brand Growth and International Expansion Strengthen Investor Outlook - kalkine.ca
Why is Cronos Group (NASDAQ:CRON) stock in focus today? - Kalkine Media
Cronos Group (NASDAQ:CRON): What's Moving During A Choppy Session? - Kalkine Media
Cronos Group (TSX:CRON) Gains Attention Amid Cannabis Sector Shifts - Kalkine Media
Can Cronos Group (TSX:CRON) Sustain Its Growth Momentum? - Kalkine Media
Cronos Group Inc. stock falls Tuesday, underperforms market - MarketWatch
Could Cronos Group Inc. (TSX:CRON) Drive Cannabis Stock Interest? - Kalkine Media
Cronos Group Inc (TSX:CRON): Why Cannabis Market Trends Matter? - Kalkine Media
Cronos Group (NASDAQ:CRON): Steady Growth Behind A Quiet Cannabis Name - Kalkine Media
Why Are These Canadian Penny Stocks Turning Heads? - Kalkine Media
Cronos Group Inc (CRON): Why This Canadian-Listed Stock Could Be One to Watch in September - kalkine.ca
Cronos Group (TSX:CRON): What's Really Driving Recent Stock Momentum? - Kalkine Media
Does Cronos Group's (TSX:CRON) New Launch Signal Growth? - Kalkine Media
Is Cronos Group’s (TSX:CRON) Live Resin Push a Turning Point for Its Brand Strategy? - simplywall.st
CRON News | CRONOS GROUP INC (NASDAQ:CRON) - ChartMill
Cronos Group (NASDAQ:CRON): Is Today’s Move A Sector Signal? - Kalkine Media
Why Is Cronos Group (NASDAQ:CRON) Posting Record Quarter as Israel Growth and New Edibles Roll Out? - Kalkine Media
Cronos Group Inc. Common Share (CRON) Key Financial Ratios – Valuation, Profitability & More - Value Research
Cannabis Stocks Spotlight: Cronos Group (TSX:CRON) Explained - Kalkine Media
Cronos Group Stock Slides as Cannabis Volatility Raises Fresh Correction Risk - kalkine.ca
Cronos Group Inc. (TSX:CRON) Falls 4.49% as Cannabis Stock Faces Profit-Taking, Regulatory Risk and Renewed Downside Pressure - kalkine.ca
Why Is Nasdaq Watching Cronos Group (NASDAQ:CRON) This Week? - Kalkine Media
Cronos Group Inc. stock falls Wednesday, underperforms market - marketwatch.com
Is Cronos Group’s Dutch Strategy A Cannabis Catalyst? - Kalkine Media
Promising Cannabis Stocks To Watch NowSeptember 2nd - MarketBeat
Are Medical Stocks Lagging Cronos Group (CRON) This Year? - Yahoo Finance
Cronos’ brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes - GlobeNewswire
Why Cronos Group (NASDAQ:CRON) Just Extended Its CanAdelaar Deadline? - Kalkine Media
Is Cronos Group (TSX:CRON) Reshaping Cannabis Markets? - Kalkine Media
Cronos Group (NASDAQ:CRON) Posts Record Revenue Amid Expansion - Kalkine Media
Top Cannabis Stocks Worth WatchingSeptember 1st - MarketBeat
How Did International Markets Reshape The Cronos Group (NASDAQ:CRON) Quarter? - Kalkine Media
Cronos Group (NASDAQ:CRON) Stays In Focus As Cannabis Reform Moves Forward - Kalkine Media
Could Cronos Group (TSX:CRON) Navigate Cannabis Market Changes? - Kalkine Media
Cronos Stock And 2 Profitable Penny Stocks With Stronger Balance Sheets - finance.yahoo.com
TSX Penny Stocks Spotlight: Cronos Group And Two More To Consider - webull.com
How Is International Expansion Reshaping the Story Around Cronos Group (NASDAQ:CRON)? - Kalkine Media
Cronos Group (NASDAQ:CRON): What Does Its Fresh Update Show About International Demand? - Kalkine Media
Cronos Group Inc. Common Share (CRON) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Cronos Group Stock Falls 5.05%: Can TSX:CRON Hold Its Ground as Cannabis-Sector Volatility Returns? - kalkine.ca
Cronos Group Stock Under Pressure — Is Cannabis Momentum Losing Steam? - kalkine.ca
Cronos Group Inc. (TSX:CRON) Gains Momentum as Cannabis Portfolio Strengthens Global Growth Outlook - kalkine.ca
Cibc World Market Inc. Invests $3.82 Million in Cronos Group Inc. $CRON - MarketBeat
What is lifting Cronos Group (NASDAQ:CRON) as cannabis reform talk resurfaces? - Kalkine Media
Cannabis Stocks To Watch TodayAugust 27th - MarketBeat
Cronos Group Inc. stock rises Wednesday, outperforms market - MarketWatch
Investors Purchase Large Volume of Cronos Group Call Options (NASDAQ:CRON) - marketbeat.com
Contra Guys: The case for Cronos Group as a contrarian bet on pot stocks - theglobeandmail.com
Cronos Group stock hits 52-week high at 3.44 USD By Investing.com - Investing.com Nigeria
Cronos Group Inc Azioni (CRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cronos Group Inc Azioni (CRON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wagner Adam | See remarks |
May 12 '26 |
Option Exercise |
0.00 |
10,367 |
0 |
103,987 |
| Buggy Shannon | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
20,622 |
0 |
187,501 |
| Kenost Jared Matthew | See Remarks |
May 12 '26 |
Option Exercise |
0.00 |
9,412 |
0 |
46,675 |
| Weigensberg Arye | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
3,118 |
0 |
211,555 |
| Wagner Adam | See remarks |
May 10 '26 |
Option Exercise |
0.00 |
20,470 |
0 |
93,620 |
| Kenost Jared Matthew | See Remarks |
May 10 '26 |
Option Exercise |
0.00 |
12,649 |
0 |
39,141 |
| Shlimak Anna | See Remarks |
Mar 19 '26 |
Option Exercise |
0.00 |
28,429 |
0 |
368,362 |
| Doucet Terrence Gregory Joseph | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
23,897 |
0 |
117,466 |
| Weigensberg Arye | See Remarks |
Mar 15 '26 |
Option Exercise |
0.00 |
24,236 |
0 |
208,437 |
| GORENSTEIN MICHAEL RYAN | See remarks below |
Mar 15 '26 |
Option Exercise |
0.00 |
324,540 |
0 |
13,340,723 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):